Home
Immunovative Therapies Ltd.

Immunovative Therapies Ltd. Market Share Analysis for May 2026

Industry: N/A

Domainimmunovative.com

Year Founded2004

Employees51 - 200

Annual Revenue$10M - $15M

Immunovative Therapies Ltd.

Immunovative Therapies Ltd. (including company regionals)

immunovative.com

See more website traffic and engagement information

Immunovative Therapies Ltd. Revenue up to May 2026 is 10M - 15M

revenue generated by Immunovative Therapies Ltd. top domains

Immunovative Therapies Ltd. top domains revenue over 3 years

Revenue for Immunovative Therapies Ltd. top domains

immunovative.com10M - 15M

See more with Sales Intelligence

Total visits to Immunovative Therapies Ltd.'s top domains

Understand Immunovative Therapies Ltd. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Immunovative Therapies Ltd.'s top domains

Analyze Immunovative Therapies Ltd. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Immunovative Therapies Ltd.'s top domains

See how Immunovative Therapies Ltd. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Immunovative Therapies Ltd. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Immunovative Therapies Ltd.

These are the website technologies, by industry, used by Immunovative Therapies Ltd. top domains

Advertising (2)

DoubleClick

Conversion & Analytics (2)

Google Analytics

Audio Video Media (1)

YouTube

Content Management System (1)

Joomla

More Technologies

5

See all

News & Signals from Immunovative Therapies Ltd.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsImmunovative Therapies Ltd. receives financing of $35M.In the past decade, Immunovative Therapies has conducted dozens of clinical trials, opened branches in California, Arizona and Thailand, and raised $35 million.

NewsChase Group partners with Immunovative Therapies Ltd..The Chase Group is pleased to announce its recent partnership and executive search engagement with the international biopharmaceutical company, Immunovative Therapies, Ltd. (ITL), currently headquartered in Israel with locations in the United States and Bangkok, Thailand.